4/A//SEC Filing
Chuang Emil 4/A
Accession 0001493152-25-021132
CIK 0001357459other
Filed
Nov 5, 7:00 PM ET
Accepted
Nov 6, 8:18 PM ET
Size
6.6 KB
Accession
0001493152-25-021132
Insider Transaction Report
Form 4/AAmended
Chuang Emil
Director
Transactions
- Award
Restricted Stock Units
2025-10-06+60,600→ 60,600 total→ Common Stock (60,600 underlying)
Footnotes (3)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock, provided that, until such time as the Issuer has sufficient shares of Issuer common stock reserved under its 2021 Equity Incentive Plan (the "Plan") to issue upon settlement of all outstanding grants thereunder, the RSUs may be settled upon vesting in cash.
- [F2]This amended Form 4 is being filed to correct the previously reported grant amount of 510,700 RSUs to the Reporting Person. The Issuer has rescinded the grant of 450,100 RSUs of the previously reported grant of 510,700 RSUs.
- [F3]The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the earlier of (i) the date of the 2026 annual meeting of stockholders or (ii) the anniversary of October 6, 2025, subject to the Reporting Person's continuous service with the Issuer through such date.
Documents
Issuer
PALISADE BIO, INC.
CIK 0001357459
Entity typeother
Related Parties
1- filerCIK 0001921045
Filing Metadata
- Form type
- 4/A
- Filed
- Nov 5, 7:00 PM ET
- Accepted
- Nov 6, 8:18 PM ET
- Size
- 6.6 KB